跳至主要内容
临床试验/JPRN-UMIN000036245
JPRN-UMIN000036245招募中未知

Clinical study on safety assessment of PRP therapy for development dysplasia of hip - Clinical study on safety assessment of PRP therapy for development dysplasia of hip

Juntendo Hospital, Juntendo university school of medicine0 个研究点目标入组 5 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with a history of hip surgery 2. Patients with abnormal platelet counts in peripheral blood 3.Person who smokes a lot (Brinkmanindex>600) 4. Treatment with anticoagulants(Warfarin) 5. Uncontrolled diabetes mellitus : HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration 6. Patients with malignancy 7. Patients less than 6 months after onset of cardiac infarction or cerebral infarction 8. Predictive survival period is less than 1 year 9. Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis) 10.Dialysis patients 11. Compromised host 12.Requiring continued use of oral corticosteroid therapy 13. Less than 20 years old 14.Doctor has determined that it is not suitable for this clinical study

研究者

发起方
Juntendo Hospital, Juntendo university school of medicine

相似试验